Page last updated: 2024-10-15

3-hydroxykynurenine and Chronic Disease

3-hydroxykynurenine has been researched along with Chronic Disease in 3 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pawlak, K1
Tankiewicz, J1
Mysliwiec, M1
Pawlak, D1
Laugeray, A1
Launay, JM1
Callebert, J1
Surget, A1
Belzung, C1
Barone, PR1
Knubel, CP1
Martínez, FF1
Acosta Rodríguez, EV1
Altamirano, A1
Rivarola, HW1
Diaz Luján, C1
Fretes, RE1
Cervi, L1
Motrán, CC1

Other Studies

3 other studies available for 3-hydroxykynurenine and Chronic Disease

ArticleYear
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:7

    Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Female; Humans; Kidney Diseases; Kynurenine; Lip

2009
Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Behavioural brain research, 2010, Jun-26, Volume: 210, Issue:1

    Topics: Animals; Brain; Chronic Disease; Depressive Disorder, Major; Disease Models, Animal; Hydroxyindoleac

2010
3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Animals; Chagas Disease; Chronic Disease; Female; Inflammation; Interferon-gamma; Kynurenine; Mice;

2011